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Abstract
Background: Consent remains a crucial, yet challenging, cornerstone of clinical practice. The ethical, legal and
professional understandings of this construct have evolved away from a doctor-centred act to a patient-centred
process that encompasses the patient’s values, beliefs and goals. This alignment of consent with the philosophy of
shared decision-making was affirmed in a recent high-profile Supreme Court ruling in England. The communication
of information is central to this model of health care delivery but it can be difficult for doctors to gauge the
information needs of the individual patient. The aim of this paper is to describe ‘core information sets’ which are
defined as a minimum set of consensus-derived information about a given procedure to be discussed with all
patients. Importantly, they are intended to catalyse discussion of subjective importance to individuals.
Main body: The model described in this paper applies health services research and Delphi consensus-building
methods to an idea orginally proposed 30 years ago. The hypothesis is that, first, large amounts of potentially-
important information are distilled down to discrete information domains. These are then, secondly, rated by key
stakeholders in multiple iterations, so that core information of agreed importance can be defined. We argue that
this scientific approach is key to identifying information important to all stakeholders, which may otherwise be
communicated poorly or omitted from discussions entirely. Our methods apply systematic review, qualitative,
survey and consensus-building techniques to define this ‘core information’. We propose that such information
addresses the ‘reasonable patient’ standard for information disclosure but, more importantly, can serve as a spring
board for high-value discussion of importance to the individual patient.
Conclusion: The application of established research methods can define information of core importance to
informed consent. Further work will establish how best to incorporate this model in routine practice.
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Background
Knowing what quantity and quality of information best
prepares patients to authorise medical procedures is an
enduring problem facing doctors. This issue has come to
prominence again with the recent English Supreme
Court ruling in Montgomery [1]. Now, the law is aligned
more closely with professional standards that require cli-
nicians to spend time with patients discussing the risks,
intended benefits, and reasonable alternative options
before seeking consent to proceed. The idea is that a
process of shared decision-making takes place that re-
sults in the doctor and patient agreeing on an appropri-
ate treatment plan that best fits the patient’s goals,
circumstance and beliefs. The era of the ‘reasonable
doctor’ standard for information disclosure has passed.
The clinician is responsible for finding out what risks or
complications associated with the intervention are ma-
terial to a reasonable person in the patient’s position or
would probably be material to the individual patient
consenting to that procedure [1].
But this is difficult. How does the clinician begin to
explore what information should be disclosed to any
given patient? How does the patient, often with little or
no baseline knowledge or understanding of what is being
proposed, start to formulate ideas about materiality and
weigh-up treatment options, so as to be ultimately satis-
fied with decisions made? It is apparent that the issue is
more complex than simply quantifying an amount of in-
formation to be disclosed. The means of communicating
that information to ensure that it is useful and under-
standable to the patient must be considered. It is this
framing of consent as a function of patient-centred com-
munication and shared decision-making that appears to
be the major shift that has come with Montgomery.
This paper tracks the evolution of the patient-centred
narrative in the law around informed consent to medical
intervention. The emphasis is on how information dis-
closure might facilitate autonomous authorisation. Per-
tinent bioethical theory is discussed before describing
the rationale and methods for a model that aims to pro-
vide a baseline from which informed consent consulta-
tions involving discussions about invasive and/or high-
risk interventions might better meet the needs of pa-
tients and clinicians alike. The focus is on how the
model fits alongside current English law but there is
relevance to other jurisdictions with similar informed
consent standards.
From Bolam, Sidaway, and Pearce to Montgomery
Testing whether or not information disclosed by doctors
has been sufficient to permit informed, autonomous
decision-making by patients has dominated case law
around informed consent over recent decades. In the
UK, several landmark cases serve to track the evolution
from physician-centred to patient-centred expectations
for standards of care. The ‘prudent doctor’ standard for
information disclosure, established in the wake of the
Bolam case in 1957 (Mr Bolam sustained limb fractures
during electroconvulsive therapy) stated that a doctor
would not be found liable in negligence if he or she
acted in accordance with a practice accepted as proper
by a responsible body of medical professionals skilled in
that particular art [2]. Thus viewed, information disclosure
was regarded as a skill possessed by medical professionals,
alongside their diagnostic and therapeutic abilities, and for
which the standards of practice were determined by the
profession. It was not until Sidaway some 30 years later
that the English courts began to acknowledge the pater-
nalistic nature of the Bolam test [3]. The claimant was un-
successful in her claim for damages resulting from not
being properly informed about the risks of spinal surgery,
but the dissenting opinion of one of the Law Lords - that
patients should ordinarily be warned of material risks, and
thus rejecting the Bolam test - was notable. Further modi-
fications, and recognition that materiality should be about
patients and not doctors, came in Pearce (an obstetric case
in which the claimant alleged being insufficiently informed
about the risks of delaying labour) and Chester (in which a
neurosurgeon was found negligent in his duty to inform
about the risks of a spinal operation) [4, 5]. But it was not
until the 2015 ruling in Montgomery, when it was ruled
that a pregnant diabetic woman should have been in-
formed about the risk of a birth complication that subse-
quently arose, that there was an emphasis in English law
on the need to find out what is material to the individual
patient: ‘[a risk is also material] if the doctor is, or should
reasonably be, aware that the particular patient would be
likely to attach significance to it’ [6].
The Supreme Court judges affirmed that it is for the
patient, and not the doctor or medical establishment, to
decide upon the materiality of risk [6–8]. The Bolam test
is no longer relevant. Clinicians are required to engage
with patients in conversations that reveal these import-
ant issues of materiality, treatment preferences, and ex-
pected outcomes. While this appears to be a welcome
shift, questions remain about whether or not patients
will be more satisfied with, and have a better under-
standing of, the information provided and discussed in
the consent consultation. One criticism of the approach
advocated in Montgomery might be that it is an abstract,
cryptic construct that only serves to further confuse
clinicians and might encourage disclosure of very large
amounts of information [7]. Truly person-centred, or
subjective, information disclosure is a laudable aim but
it is not yet known whether it can be a realistic one [9].
Patient-centred care is now a major principle for
healthcare delivery, and models like ‘shared decision-
making’ require a collaborative deliberation between the
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patient and doctor that results in a mutually satisfactory
treatment choice [10]. The ruling in Montgomery aligns
the constructs of informed consent and shared decision-
making more closely, and emphasises the need for a
process rather than a single act [8]. The common thread
running through these constructs is information: infor-
mation that is disclosed, exchanged, useful, and under-
standable. The nature of this information is likely to be
different for each patient but we hypothesise that there
is a common, core amount of information that is not
only important to all patients (‘prudent’ patients) but is
also required to catalyse those discussions that meet the
subjective information needs of individuals. This model
offers clinicians a framework on which to base consent
consultations that better meet the requirements laid
down in Montgomery. Before describing our methodo-
logical approach to addressing our hypothesis, the next
section outlines the rationale for ‘core information sets’
for informed consent.
Core information sets
Our model is built around an interpretation of the ‘core
disclosure’ concept described in Faden and Beauchamp’s
seminal text [11]. The underlying premise is that while
truly patient-centred, subjective information disclosure
and exchange may be desirable, most patients require
some level of baseline information on which to base fur-
ther discussion, formulate questions, and make decisions
about their health. Healthcare information may now be
more readily available but it is increasingly complex. In
addition, there can be concerns over its accuracy and
relevance, and there may be no evidence that the patient
understands it. Furthermore, variation in the quality and
quantity of information disclosed in consent consulta-
tions was highlighted as a problem in Montgomery. It
appears apt, therefore, to address this issue with the aim
of improving practice. The ‘core disclosure’ approach -
whereby a baseline amount of information is identified
as important by key stakeholders – is, therefore, as rele-
vant now as it was 30 years ago. It has the potential to
catalyse information exchange that is of value to the pa-
tient, but crucially also recognises the clinician’s role in
informed consent consultations. As far as we are aware,
our methodological approach to developing this idea is
novel. We have approached it pragmatically by applying
scientific methods. Before outlining these, the intended
scope and use of core information sets will be described,
in order to contrast them with existing models for
consultations, namely shared decision-making using de-
cision aids.
Defining the scope of the core information set
A core information set is intended for use when a pa-
tient is ready for a detailed discussion about a treatment
recommendation or decision. To date, we have developed
core information sets in three areas of surgical oncology
where an operation is a major component of a patient’s
treatment. It is envisaged that core information sets will
form the basis of encounter tools [12] that help guide the
patient, their families, and clinicians through the informa-
tion domains that have been derived through consensus-
building work. Although conceptually similar to patient
decision aids [10], a single core information set-as pres-
ently conceived-does not directly compare the out-
comes associated with different treatment options.
Rather, core information sets are intended to ensure
that information that has been shown to be important
to patients, but often not discussed by doctors, is in-
cluded in pre-operative consultations.
Defining the procedure to which the core information
set applies is, therefore, required at the outset. It is im-
portant to clarify at this point that CIS are not intended
as a panacea for information provision. We do not advo-
cate a ‘tick box’ approach to informed consent consulta-
tions but instead aim to provide baseline information
that is of proven importance to patients and clinicians,
and which acts as a springboard for further discussion.
Information about viable alternative therapeutic ap-
proaches must be included in prior discussions. The
core information set is, however, intended as a focussed
starting point for detailed conversation about a particu-
lar procedure once that procedure has been agreed
upon, meaning that alternative procedures will need a
similar disclosure of information. The potential strengths
and weaknesses of this approach are explored later, but
first we outline the methods we have used to define core
information sets for securing the informed consent of
patients to particular surgical procedures.
Methodological approach
Our mixed-methods approach applies health services re-
search and consensus-building techniques. Initially, a
wide net is cast that aims to capture information that
may be important for informed consent. Interviews and
surveys using scientific methods, and involving key
stakeholders, distill this large amount of information
down to a core set. The overall methodological approach
is outlined in the next four sub-sections. A more de-
tailed description of the application of the methods have
been published elsewhere [13], so the emphasis here is
on explaining how a pragmatic scientific approach can
be applied to our theoretical model for informed con-
sent. Development of core information sets involves four
main phases, as shown in Fig. 1. As will be seen, some
of this work involves in-depth, iterative qualitative
inquiry that is resource intensive to do well. Where pos-
sible, therefore, we have identified alternative methods
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that may better suit researchers with different expertise
and/or resources.
Collating relevant information
Information that may be relevant for discussion during
the informed consent process can be collated from
several sources (Table 1). Sensitive, systematic literature
searches can identify papers reporting those clinical and
patient-reported outcomes that might inform decision-
making or treatment guidelines. Included articles should
ideally reflect current practice, and consideration ought
to be given to the time frame for the measurement of
outcomes (e.g. short versus long term). Those outcomes
of interest can be recorded verbatim from the papers for
later consideration.
Information included in patient information leaflets
(PILs) provided by hospitals, specialty associations, and
national charities can be collated. This is important be-
cause patients and their families are known to use these
resources to augment information discussed in clinic
[14]. These PILs contain information about, for example,
the process of care and surgery that may be relevant for
informed consent but not communicated in the scien-
tific literature described above. It is important, however,
Fig. 1 Phases in the development of a core information set for consent to oesophagectomy [13]
Table 1 Potential methods for gathering information of
importance to clinicians and patients
• Written information
◦ Scientific papers reporting clinical and/or patient-reported outcomes
of relevance
◦ Written information leaflets provided for patients by hospitals and
other organisations
◦ Websites produced by charities, hospital units, and patient support
groups
◦ National audit, guidelines, and policy documents
• Information of importance to individuals
◦ Delphi questionnaires
◦ Nominal group techniques
◦ Focus groups
◦ Individual in-depth interviews with clinicians and patients
◦ Recordings of consultations
◦ Individual questionnaires
◦ Patient experience resources, including websites
(e.g. HealthTalk On Line)
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to take account of potential inaccuracies contained
within them [15]. Rather than relying on PILs as reliable
sources of, for example, complication rates, it is recom-
mended that the categories of information are recorded
for further consideration later in the process. Additional
sources of written healthcare information that may be
analysed include national guidelines and audit docu-
ments. There is likely to be a large amount of potentially
relevant information on internet web pages that could
be included here.
Patients and clinicians can be given opportunities to
report information of particular importance to them, but
which may not be captured by other methods. Qualita-
tive research methods such as non-participant observa-
tion and semi-structured interviews, for example, allow
in-depth exploration of what information is exchanged
during the consent process, and what information is
most valued by patients [16]. Audio recordings of con-
sent consultations will identify what information is dis-
cussed during consultations, and how questions are
asked by patients and answered by clinicians. More simple
methods for allowing patients and clinicians to express
their views about what information is important include
open-ended questions incorporated into surveys or ques-
tionnaires used in other stages of CIS development.
Careful consideration should be given to which key
stakeholder groups are included in this phase of work.
Different groups are likely to place different emphases
on different types of information, and it is essential that
patients are consulted. Healthcare workers may be more
homogenous in their views compared with groups of pa-
tients, particularly when considering information about
quality of life, body image, or social functioning [17]. It
is important that sufficient patient representation is in-
cluded to allow these differing views to be captured. We
have found that purposively including patients at varying
stages along the pre- and post-treatment trajectory leads
to a comprehensive capture of important issues about
which patients would value information. Expert patients,
patient support group members, and family members of
patients have all participated in our work to add depth
to the views captured during the consensus-building
phases.
At the end of this phase, additional information items
identified are added to the ‘long list’ that is collated fol-
lowing reviews of the scientific and other written
information.
Categorising the information
There will be significant duplication and overlap in the
information items collated in the initial phase of work.
Duplicated items can be combined into broader
‘domains’ of healthcare information [13]. Thirty- and 90-
day mortality would, for example, be included in a
‘mortality’ domain. This is a key step in the development
of CIS because inappropriate categorisation of informa-
tion may allow important meanings or differences to be
lost. Both patients and clinicians can be involved in a
‘think aloud’ approach, whereby the participant is guided
through the process by a researcher and asked to place
each item of information in an appropriate domain that
includes similar items [18]. Decisions are documented
for transparency and subsequent peer review. The final
domain list is then taken forward for prioritisation by
stakeholders.
Prioritising the information
Consensus-building methods can be applied to allow key
stakeholders, including patients, to prioritise the infor-
mation domains. The Delphi process, for example, is a
survey technique that aims to guide independent, an-
onymous participants towards consensus in a structured
way [19]. A principal advantage is that it can be con-
ducted by post or email in a participant’s own time and
space, meaning the potential influence of dominant per-
sonalities potentially encountered in a face-to-face group
setting is minimised [20].
There is no statistical way of determining sample size
for Delphi studies. We recommend selecting a sample
size based on numbers of stakeholder groups, and antici-
pated variation based on key characteristics. As de-
scribed above, it may be reasonable to expect healthcare
professionals to be more homogenous in their views
than patients. This technique is, however, time consum-
ing and can involve a significant administrative burden.
There is the potential, as with other questionnaire tech-
niques, of significant attrition or failure-to-respond. It is
important, therefore, to pilot any questionnaire with
representatives of stakeholder groups to ensure the
questionnaires are user friendly, with easy-to-follow in-
structions and straightforward layout, to help maximise
fidelity. We have found patient support group represen-
tatives to be extremely valuable in this process. Depending
on resources and expertise, therefore, a focus group or
other method of building consensus may be more appro-
priate [19].
If a Delphi-approach is taken to elicit expert opinion,
the information domains formulated in the previous
phase are formatted into a questionnaire. Participants
are asked to prioritise the list of domains on a Likert
scale ranging from “not important” to “extremely im-
portant”. Cut-off criteria are applied to determine which
items should be retained and which should be discarded.
There is no agreement about how best to determine these
criteria in Delphi studies [20]. However, if the aim is to de-
termine information of most importance, it is feasible that
a large majority (for example greater than 70%) should
rate the information “extremely important” [13]. Data
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from the first round of questionnaire surveys is sum-
marised to produce feedback that may include data
such as the mean group score. A second questionnaire
containing the retained items is developed. It includes
the individual participant responses from the first
round and the mean scores of patients and profes-
sionals for each domain. Participants are then asked to
re-prioritise each remaining domain in light of the feed-
back data provided.
A priori criteria are applied to the responses from
the second Delphi round, and information domains
considered highly important are retained. All other in-
formation domains are discarded from the process,
and not included in the final CIS. These domains con-
tain information that may still be discussed in consent
consultations and prove important to any individual
patient but are not, by definition, core information
valued by a majority of stakeholders.
Finalising the core information set
Information domains retained after the Delphi process
can be discussed in group consensus meetings. These
meetings aim to structure interaction within a group
through a process of anonymous voting and subsequent
discussion. Separate meetings for patients and profes-
sionals are recommended to enable patients to express
their views freely. Consideration for inclusion in the
CIS is debated through moderated discussion. Real-
time voting technology (e.g. Turning Point©) can be
used to collate stakeholders’ views on whether or not
each domain should be included in the final set,
whereby participants are asked to vote “in”, “out”, or
“unsure” for each domain. Those domains clearly voted
“out” by a majority are discarded. Those for which
there is an equivocal result (“unsure” or an even split
between “in” or “out”) are re-presented to the group.
Discussion and re-voting continue until consensus is
reached on every domain.
At the end of this phase, the CIS obtained from each
consensus meeting will typically contain around 10
domains. An important final step is to discuss the
content of the core information sets with consensus
meeting participants in order to gauge its appropriate-
ness and reflect on any dissenting opinion. If required,
further voting and discussion can take place. The pa-
tient and professional sets are compared and then
condensed into a single set of core information for in-
formed consent to the specific procedure. Figure 1
uses a CIS developed for patients about to undergo
oesophagectomy to summarise the suggested steps,
and to illustrate the organization and prioritisation of
large amounts of information to the core of eight
domains [13].
Discussion and conclusions
Medical intervention requires a patient’s authorisation.
This ethical, legal, and professional requirement is rea-
lised through a process of information provision and ex-
change aimed at reaching informed consent. Despite a
wealth of theory, guidance, and legal precedent, this area
of clinical practice remains challenging [21]. Fundamen-
tal to the process should be the communication of infor-
mation that is: useful and understandable to the patient;
allows him or her to weigh up the potential benefits and
risks of the procedure; and results in a decision that best
fits his or her goals and circumstances [22–24]. Knowing
how much and what kind of information about a given
procedure achieves these aims is difficult. Practice might
not meet bioethical ideals, patients may lack informa-
tion, and clinicians may be at risk of litigation. Promin-
ent bioethicists and others have realised that efforts are
required to provide understandable information of rele-
vance to patients and professionals [11, 21]. Core infor-
mation sets are part of a potential solution. Consisting
of information of agreed importance about a given pro-
cedure, they would reduce variation in the practices of
information provision about a given procedure, and be a
starting point for the development of interventions to
improve informed consent.
The fact that a landmark legal case in England recently
reignited debate about how best to inform patients about
a proposed intervention only serves to highlight the
timely need for our work [6]. We are not the first to at-
tempt to address informed consent from a frontline,
service-delivery based perspective but little previous
work has had an impact on practice. A recent Cochrane
review of trials of interventions that aimed to improve
consent showed that most were developed in a superfi-
cial way, with little theoretical basis for how information
about the medical procedure was selected for inclusion
[25]. The interventions were not piloted before evalu-
ation in randomised trials; little training was given to
those using the interventions; fidelity to the intervention
protocols was not reported; and the standard care com-
parator was poorly described and monitored in most
studies. The majority of studies were, in addition, small
and addressed only the patients’ perspectives on in-
formed consent. That is, no intervention aimed to
change clinicians’ practice. There was limited follow-up,
thus failing to capture potentially important longer-term
outcomes including litigation or decisional regret. It ap-
pears, therefore, that much effort goes into multiple
small scale studies, but these do not subsequently im-
prove daily clinical practice.
There is a need for a theoretical basis for developing
interventions that involve patients in the process, and
for these to be piloted in practice. Training those who
will be delivering the intervention is also required
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because simply providing patients and clinicians with a
list of information domains for discussion is unlikely to
satisfy modern legal, ethical, and professional standards.
Indeed, such an approach risks a regressive, paternalistic
practice that is counter to accepted bioethical principles.
These issues require an in-depth investigation that does
not concentrate solely on the disclosure of risk but aims
to develop an innovative approach to consent that is em-
bedded in a model of doctor-patient communication
that addresses those issues of importance and additional
value to the patient, including survival and quality-of-life
[26]. Before this, a proper understanding of the nature of
what information is most important to patients and
others is required.
The approach presented in this paper aims to establish
what information is rated as most important by patients
and clinicians for discussion during the informed con-
sent process. It is one way of starting to address the
broader issues related to information, including ensuring
understanding, facilitating deliberation, and permitting
recall. Key strengths include the systematic application
of health services research methods. This allows a repro-
ducible and transparent way of prioritising complex in-
formation. Patients are involved in every stage, which is
crucial if we are to understand how and why patients
prioritise core information. As discussed earlier, it is not
the intention that CIS should encourage a ‘tick-box’
approach to informed consent consultations whereby cli-
nicians view the domains within it as a panacea. This
would be an undesirable outcome because the intention
of this model is to foster a patient-centred approach to
informed consent. The key to addressing this will be fu-
ture work that assesses how best to implement core in-
formation sets in routine practice, as well as which
outcomes should be measured in evaluative work that
assesses their effectiveness.
The core information set could form the basis of an
intervention to train clinicians to discuss these key is-
sues of importance to patients. The core information set
might, for example, be operationalised as a consultation
agenda that prompts surgeons to discuss the domains
with all patients while also seeking to engage patients in
a two-way dialogue. The intervention might involve an
initial, facilitated training session using simulated clinical
scenarios in which trained medical actors play the role
of patients and guided by suggested competencies for in-
formed, shared decision-making [27]. Different scenarios
would be used to train, and subsequently test, the sur-
geons’ abilities to use the core information set to gain
patients’ consent (or not) to proceed with surgery. Con-
sultation observation and scoring instruments have been
developed in the field of shared decision-making and it
might be feasible to apply aspects of these instruments
to the assessment of recorded consent consultations. In
addition, conversation analysis techniques could be ap-
plied that would help explain why certain ways of com-
municating the core information set result in better
consultations. Interviews with surgeons after consulta-
tions would provide insight into positive and negative
aspects of the intervention. The aim would be to gather
evidence about what works, what does not work, and
why? These initial stages, or pilot work, would serve as a
field-testing of the core information set and examples of
good practice would be developed into tools that help
facilitate better consultations. We acknowledge that the
model described above requires significant research and
time resources. Future work will, in addition to address-
ing how to implement core information sets in practice,
aim to streamline the process of development. There is
scope to refine, and speed-up the initial steps in core in-
formation set development including addressing whether
in-depth systematic reviews are required, and whether
focus group work might work as well as individual, in-
depth interviews. We also hypothesise that, based on
core sets developed thus far, there will be areas of com-
monality and overlap between sets developed for differ-
ent procedures (for example, ‘survival’ or ‘long term
quality of life’ in surgical oncology). A growing reposi-
tory of core information sets will help identify such areas
of overlap in order to negate the requirement for some
of the developmental work.
Our model is framed as a means of respecting an indi-
vidual’s need for information in order to provide an
autonomous authorisation, or refusal, of a proposed
medical intervention. This justification for informed
consent is not universally accepted, in part because of
the fact that, in the majority of cases, treatment options
are presented to patients by doctors and thus ‘true’
autonomy (where, for example, the patient presents with
a request for a particular treatment and the expectation
is that it will be carried out) does not result [9, 28]. It
should be recognised that patients may not be equipped
with a background level of training, knowledge, or un-
derstanding that would allow them to formulate treat-
ment plans independently. It is on this latter construct
of autonomy that our core information model is based.
The aim of our work is to better equip patients with the
information that helps them make the decision that is
best for them within the resources available and to bet-
ter equip doctors to guide patients through that process.
The proof of effectiveness of this model will require it
to successfully deliver the outcomes of informed con-
sent, however those are defined. At the very least, it will
need to result in patients having sufficient understanding
of the proposed treatment and its alternatives to make
their authorisation or refusal of it meaningful to the
individual. Linked to this is that the model must be
viewed by clinicians as a credible tool that enhances
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consultations rather than hindering them, making them
longer, or otherwise disruptive [29]. A key assumption
made in this account of our model is that all patients
have the capacity to fully participate in the informed
consent process. Further work will be required to ex-
plore the applicability of this model in situations where
capacity may be diminished. Similarly, the acceptability
of core information to different ethnic groups, for whom
information provision in the medical setting might be
valued in different ways, will require careful and sensi-
tive consideration.
To date, we have successfully applied these methods
to define a core information set in one area of surgical
oncology. Our early work suggests this approach is ac-
ceptable to patients and clinicians. Work is ongoing to
develop other core information sets and we have begun
the process of exploring how best to incorporate core in-
formation as an effective tool in clinical consultations
which results in patients making decisions that reduce





JLD is a National Institute for Health Research Senior Investigator
JMB-this work was undertaken with the support of the MRC CoNDuCT-II Hub
(COllaboration and iNnovation for DifficUlt and Complex randomised controlled
Trials In Invasive procedures)-MR/K025643/1 and Bristol Surgical Trials Centre.
She is a NIHR Senior Investigator.
The views expressed are those of the authors and not necessarily those of
the MRC, NHS or NIHR.
Availability of data and materials
Not applicable.
Authors’ contributions
BM-built on the concept of core information sets, wrote the first draft and
contributed to all drafts of the paper. AM-developed the concept of core
information sets for informed consent in surgery, and contributed to all
drafts of the manuscript. RH-advised on legal and ethical principles, and
contributed to all drafts of the manuscript. JLD-advised on qualitative
methods and critiqued the manuscript. PK-contributed to the development
of our thinking on the place of core information methods and more broadly
on how clinicians and patients can contribute to the process. He contributed
to all drafts of the manuscript. SJT-commented on the manuscript.
JMB-developed the concept of core information sets for informed consent in
surgery, and contributed to all drafts of the manuscript. All co-authors provided
substantial contributions to the conception and design of the work, drafting and
revising the manuscript, and have agreed on the final version to be published.
The co-authors are accountable for all aspects of the work in ensuring that
questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolve.
Competing interests
Professor Richard Huxtable is a section editor for BMC Medical Ethics.
Professor Richard Huxtable is a section editor for BMC Medical Ethics. None of
the remaining authors have competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Centre for Surgical Research, School of Social and Community Medicine,
University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
2School of Oral and Dental Sciences, University of Bristol, Bristol BS1 2LY, UK.
3Division of Surgery, Head and Neck, University Hospitals Bristol NHS
Foundation Trust, Bristol BS2 8HW, UK. 4Centre for Medical Education,
University of Cardiff, Cardiff CF14 4YU, UK.
Received: 9 November 2016 Accepted: 14 April 2017
References
1. Sokol DK. Update on the UK law on consent. BMJ. 2015;350:h1481.
2. Bolam v. Friern HMC [1957] 2 All ER 118.
3. Sidaway v. Bethlem Royal Hospital Governors [1985] AC 871
4. Pearce v. United Bristol Healthcare NHS Trust [1999] 48 BMLR 118.
5. Chester v. Afshar [2004] UKHL 41
6. Montgomery v. Lanarkshire Health Board (Scotland) [2015] UKSC 11
7. Heywood R. R.I.P. Sidaway: Patient-oriented disclosure - a standard worth
waiting for? Montgomery v Lanarkshire Health Board [2015] UKSC 11. Med
Law Rev. 2015;23(3):455–66.
8. Dire C. Doctors must not cherry pick information to give patients, landmark
case determines. BMJ. 2015;350:h1414.
9. O’Neill O. Some limits of informed consent. J Med Ethics. 2003;29:4–7.
10. Edwards A, Elwyn G, editors. Shared decision-making in health care:
Achieving evidence-based patient choice. 2nd ed. Oxford: Oxford University
Press; 2009.
11. Faden RR, Beauchamp TL. A history and theory of informed consent.
Oxford: Oxford University Press; 1986.
12. Elwyn G, Montori VM. Tools to engage patients in clinical encounters. In:
Elwyn G, Edwards A, Thompson R, editors. Shared decision making in health
care: achieving evidence-based patient choice. 3rd ed. Oxford: Oxford
University Press; 2016. p. 57–63.
13. Blazeby JM, Macefield R, Blencowe NS, Jacobs M, McNair AG, Sprangers M.
Core information set for oesophageal cancer surgery. Br J Surg. 2015;102(8):
936–43.
14. McCartney M. Patient information leaflets: “a stupid system”. BMJ. 2013;
347:f4748.
15. Blencowe NS, Strong S, McNair AG, Howes N, Elliot J, Avery KN, Blazeby JM.
Assessing the quality of written information provision for surgical procedures:
a case study in oesophagectomy. BMJ Open. 2015;5(10):e008536.
16. Hammersley M, Atkinson P. Ethnography. Principles in practice. 3rd ed.
Abingdon: Routledge; 2007.
17. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E,
Tugwell P. Developing core outcome sets for clinical trials: issues to
consider. Trials. 2012;6(13):132.
18. Charters E. The use of think-aloud methods in qualitative research. An
introduction to think-aloud methods. Brock Educ. 2003;12(2):68–82.
19. Jones J, Hunter D. Consensus methods for medical and health services
research. BMJ. 1995;311:376–80.
20. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey.
J Adv Nurs. 2000;32:1008–15.
21. Grady C. Enduring and emerging challenges of informed consent. N Engl J
Med. 2015;372:855–62.
22. Department of Health. Reference guide to consent for examination or
treatment. Available online at https://www.gov.uk/government/
publications/reference-guide-to-consent-for-examination-or-treatment-
second-edition. Accessed 20 Apr 2017.
23. Royal College of Surgeons. Professional standards for cosmetic practice.
Available online at https://www.rcseng.ac.uk/standards-and-research/
standards-and-guidance/service-standards/cosmetic-surgery/professional-
standards-for-cosmetic-surgery/. Accessed 20 Apr 2017.
24. General Medical Council. Press Release. Give patients time to think before
cosmetic procedures, doctors told. Available online at http://www.gmc-uk.
org/news/26550.asp . Accessed 20 Apr 2017.
25. Kinnersley P, Phillips K, Savage K, Kelly MJ, Farrell E, Morgan B, et al.
Interventions to promote informed consent for patients undergoing
Main et al. BMC Medical Ethics  (2017) 18:29 Page 8 of 9
surgical and other invasive healthcare procedures. Cochrane Database Syst
Rev. 2013;7:CD009445.
26. Main B, McNair A, Davis L, Blazeby JM. Bringing informed consent back to
patients. Available online at http://blogs.bmj.com/bmj/2014/08/05/barry-main-
et-al-bringing-informed-consent-back-to-patients/. Accessed 20 Apr 2017.
27. Towle A, Godolphin W. Framework for teaching and learning informed
shared decision making. BMJ. 1999;319:766–71.
28. Huxtable R. Autonomy, best interests and the public interest: treatment, non-
treatment and the values of medical law. Med Law Rev. 2014;22(4):459–93.
29. Wear S. Informed consent. Patient autonomy and clinician beneficence
within health care. 2nd ed. Washington D.C: Georgetown University Press;
1998. p. 81–99.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Main et al. BMC Medical Ethics  (2017) 18:29 Page 9 of 9
